Archive

Latest KFF Health News Stories

Inviting Patients To Help Decide Their Own Treatment

KFF Health News Original

At UC San Francisco and other hospitals and clinics around the nation, “shared decision making” programs encourage doctors and patients to work together in making tough choices about care. 

In Texas Funding Fight, Cancer Care For Poor Women Could Be Collateral Damage

KFF Health News Original

GOP lawmakers eager to cut off funding to Planned Parenthood are weighing changes to a cancer screening program for poor women. But private clinics unaffiliated with Planned Parenthood say they’d take a hit, too.

Health Coverage In Limbo For Many Small-Business Employees

KFF Health News Original

About a half-million Washingtonians get health insurance through associations or trusts. But the future of such plans is under review by state regulators, and so far many of the plans have been rejected.

Retail Health Care Spurs Innovation In South Florida

KFF Health News Original

In September, Florida Blue will debut three “integrated care” facilities designed to cater to South and Central American populations by offering primary care, specialty services, labs and diagnostics under one roof — a model common in Latin America.

Republican Lawmakers Sink Montana Governor’s Medicaid Expansion Plan

KFF Health News Original

A House committee gives the bill a “do not pass” recommendation, which effectively kills Democrats’ efforts to get it on the House floor. A Republican counter-proposal that includes premiums and co-payments for Medicaid enrollees may come out of the state Senate.

Mental Health Providers Look For Federal Incentives To Go Digital, Too

KFF Health News Original

The federal government is spending $26 billion to get doctors and hospitals to move to digital records to help coordinate care, but the funding does not include mental health clinics, psychologists and psychiatric hospitals.

FDA Heads Into Uncharted Territory Of ‘Biosimiliar’ Drugs

KFF Health News Original

Under a new process set out by the health law, the FDA approved the first so-called biosimilar drug for sale in the U.S. It’s a copy of the cancer medicine Neupogen that will be sold under the brand name Zarxio.

Hundreds Of Hospitals Struggle To Improve Patient Satisfaction

KFF Health News Original

Pleasing patients has become more important to hospitals as Medicare takes consumers views into account when setting payments. Most hospitals are getting better, but others have not improved since the government started publishing ratings six years ago.